Manufacturer record

Vivimed Labs Limited: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

8 batches manufactured by Vivimed Labs Limited (Telangana) were declared Not of Standard Quality between August 2020 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

8 records linked to Vivimed Labs Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
8Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2020 to May 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

8
NSQ batches since 2020
8
Products affected
Assay
Most common failure
May 2026
Latest alert

Flagged batches per year

2020 · 12022 · 22023 · 22024 · 12026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Aspirin Gastro-resistant and Atorvastatin Capsules IP (75mg/10mg) AAC5053Mfg 2025-07 · Exp 2027-06 The sample does not conforms to I.P.2022 with respect to the Test for Related substances for Aspirin and Atorvastatin.Related substances CDTL, MumbaiCDSCO lab May 2026
Ear wax softening drops, 5CU01Mfg 2025-03 · Exp 2027-02 The sample received does not conform to manufacturer?s specification with respect to the test for Assay for the contents of Paradichlorobenzene, Chlorbutol and Turpentine OIL only.Assay CDTL, HyderabadCDSCO lab Mar 2026
Paracetamol Paediatric Oral Suspension IP V0244001Mfg 2024-02 · Exp 2026-01 Related SubstancesRelated substances CDTL MumbaiCDSCO lab Sep 2024
Tropicamide Eye Drops IP 1 % w/v GTC002Mfg 2022-05 · Exp 2024-04 Sterility & AssayAssay CDTL MumbaiCDSCO lab Jul 2023
Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP TE2027AMfg 2022-05 · Exp 2024-04 DescriptionDescription CDL KolkataCDSCO lab Jan 2023
FERROUS ASCORBATE & FOLIC ACID CAPSULES 1013Mfg 2021-12 · Exp 2023-11 AVERAGE FILL AND ASSAY FOLIC ACIDAssay CDTL HyderabadCDSCO lab Dec 2022
Ranitidine Oral Solution I.P. 100mL 2005Mfg 2022-02 · Exp 2023-07 ASSAYAssay RDTL GuwahatiState lab Nov 2022
Winpress-XL 5mg (Prazosin Hydrochloride Sustained Release Tablets) PST9001Mfg 2019-02 · Exp 2021-01 DissolutionDissolution CDL KolkataCDSCO lab Aug 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.